Pan, Xin’an
Chang, Yingjun
Ruan, Guorui
Zhou, Songhai
Jiang, Hao
Jiang, Qian
Huang, Xiaojun
Zhao, Xiao-Su
Funding for this research was provided by:
the Beijing Municipal Science and Technology Commission (Z221100007422008, Z221100007422008)
the Major Program of the National Natural Science Foundation of China (82293630 and 82293633)
National Key Research and Development Program of China Stem Cell and Translational Research (2021YFC2500300)
Article History
Received: 29 September 2023
Accepted: 16 January 2024
First Online: 13 February 2024
Declarations
:
: The authors declare no competing interests.
: Our study was approved by the Medical Ethics Committee of Peking University People's Hospital, and the approval code is ChiCTR1800016458.
: All patients provided written informed consent; there was no financial compensation.